Rolipram
CAS No. 61413-54-5
Rolipram( SB95952 | ZK62711 | (R,S)-Rolipram | SB 95952 | ZK 62711 | SB-95952 | ZK-62711 )
Catalog No. M15314 CAS No. 61413-54-5
A potent, selective inhibitor of phosphodiesterases PDE4 with IC50 of 3 nM, 130 nM and 240 nM for PDE4A, PDE4B, and PDE4D, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 10MG | 41 | In Stock |
|
| 50MG | 57 | In Stock |
|
| 100MG | 81 | In Stock |
|
| 200MG | 119 | In Stock |
|
| 500MG | 197 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRolipram
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective inhibitor of phosphodiesterases PDE4 with IC50 of 3 nM, 130 nM and 240 nM for PDE4A, PDE4B, and PDE4D, respectively.
-
DescriptionA potent, selective inhibitor of phosphodiesterases PDE4 with IC50 of 3 nM, 130 nM and 240 nM for PDE4A, PDE4B, and PDE4D, respectively; increases phosphorylation of CREB in U937 cells in a dose-dependent fashion, dose-dependently inhibits the IFN-gamma-stimulated phosphorylation of p38 MAPK with IC50 of 290 nM; inhibits TNF production, attenuates carrageenan-induced paw inflammation in mice.Asthma Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsSB95952 | ZK62711 | (R,S)-Rolipram | SB 95952 | ZK 62711 | SB-95952 | ZK-62711
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE4B|PDE4D
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number61413-54-5
-
Formula Weight275.3428
-
Molecular FormulaC16H21NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 41 mg/mL
-
SMILESO=C1NCC(C2=CC=C(OC)C(OC3CCCC3)=C2)C1
-
Chemical Name2-Pyrrolidinone, 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
AWD 12-281
AWD 12-281 is a selective phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory and bronchodilator activity used in the study of chronic obstructive pulmonary disease (COPD).
-
MBCQ
MBCQ is an inhibitor of cGMP-specific phosphodiesterase PDE5.MBCQ, a selective PDE5 inhibitor, significantly decreased the EC(50) values for GTN-induced relaxation in both tolerant and nontolerant tissues, but with the greatest relative shift occurring in tolerant veins.
-
N-Ethyl tadalafil
N-Ethyl tadalafil (NEthyl tadalafil) is a CGMP-specific 3',5'-cyclic phosphodiesterase (PDE) inhibitor used in the study of cardiovascular diseases such as angina pectoris, hypertension, and pulmonary hypertension.
Cart
sales@molnova.com